05Dec 2023
Timing of antenatal corticosteroids and survival without neurologic disabilities at 5½ years in children

Timing of antenatal corticosteroids and survival without neurologic disabilities at 5½ years in children

This secondary analysis of the EPIPAGE-2 study evaluated the impact of antenatal corticosteroid timing on survival without moderate or severe neurologic disabilities at 5½ years. The study included 2613 children born alive between 24+0 and 34+6 weeks in France. Survival without neurologic disabilities was lower when the interval between corticosteroid administration and birth exceeded 7 days. The findings underscore the importance of optimizing the timing of antenatal corticosteroid treatment for women at risk of preterm delivery to enhance its benefits on long-term neurodevelopmental outcomes.

  • #gynaecology - ivf

Like

Save

Share